Skip to content

Studies finds risks in guided treatment interruptions even at higher CD4 cell threshold

Asthma drug provides effective treatment for immune reconstitution inflammatory syndrome

One-in-six interrupt treatment within two years of initiating ART

SMART study - treatment breaks lower quality of life

New data shed light on poor outcome in SMART study

Staccato study suggests that some CD4-guided treatment interruptions can be safe

Study concludes that interleukin-2 has no benefit before HIV treatment interruptions, but increases side-effects

Variation in gene linked to risk of resistance after stopping efavirenz treatment

Treatment interruption arm of DART study halted